Printer Friendly

HOLOGIC, INC. ANNOUNCES FIRST QUARTER 1992 RESULTS

 HOLOGIC, INC. ANNOUNCES FIRST QUARTER 1992 RESULTS
 WALTHAM, Mass., Jan. 30 /PRNewswire/ -- Hologic, Inc.


(NASDAQ: HOLX) today announced its results for the first quarter ended Dec. 31, 1991, reporting net income of $311,154 or 8 cents per share, compared with a loss of $78,162, or 2 cents per share, for the first quarter of fiscal 1991. First quarter revenues increased 42 percent to $5,468,367 from $3,862,859 for the first quarter of fiscal 1991 and increased 5 percent from $5,214,654 for the fourth quarter of fiscal 1991.
 "We are pleased with the growing acceptance of our new model, the QDR-2000 Supine Lateral Bone Densitometer, for both research and clinical applications," said S. David Ellenbogen, president and CEO. "The QDR-2000 represented over one-half of our total revenue for the quarter."
 Ellenbogen said that U.S. sales activity accounted for 40 percent of this quarter's total revenue. This represented an increase over previous quarters due in part to a growing awareness of osteoporosis, an increase in sales to pharmaceutical companies interested in developing new drug therapies for osteoporosis, and the continued strong efforts and expansion of Hologic's U.S. direct sales force.
 "In the months ahead," Ellenbogen continued, "the company should see additional benefits from our new European headquarters, opened this past October in Brussels. This operation is already increasing our direct presence in Europe and improving our post-sales support. We are in the process of opening two additional direct sales and service operations in France and Spain."
 Hologic, Inc. develops, manufactures and markets proprietary X-ray systems. With more than 850 installations worldwide, the company's QDR X-ray bone densitometers are used for the precise measurement of bone density to assist in the diagnosis and monitoring of osteoporosis and other metabolic bone diseases. Osteoporosis, a condition characterized by decreased bone density and increased risk of fractures, occurs in at least one of three women over the age of 65.
 HOLOGIC, INC. AND SUBSIDIARIES
 Consolidated Statements of Income
 (Unaudited)
 Three months ended
 Dec. 31,
 1991 1990
 Revenues:
 Product sales $5,316,443 $3,070,517
 Research and development contract ---- 551,156
 Interest income 151,924 241,186
 Total 5,468,367 3,862,859
 Costs and Expenses:
 Cost of product sales 2,655,127 1,997,278
 Research and development 777,200 1,061,889
 Selling and marketing 953,230 578,976
 General and administrative 638,656 335,878
 Total 5,024,213 3,974,021
 Income (loss) before
 provision for income taxes 444,154 (111,162)
 Provision (benefit) for income taxes 133,000 (33,000)
 Net income (loss) $311,154 $(78,162)
 Net income (loss) per common and
 common equivalent share:
 Primary 8 cents (2 cents)
 Weighted average number of common
 and common equivalent shares
 outstanding
 Primary 4,049,004 3,832,613
 HOLOGIC, INC. AND SUBSIDIARIES
 Consolidated Balance Sheet
 12/31/91 9/30/91
 (Unaudited) (Audited)
 ASSETS
 Current Assets:
 Cash and cash equivalents $4,835,014 $9,032,209
 Short-term investments 6,699,997 2,833,745
 Accounts receivable, net of
 allowance for doubtful accounts
 of $125,000 3,692,873 3,431,287
 Inventories 2,811,707 2,894,246
 Prepaid expenses and other
 current assets 620,445 446,531
 Total current assets 18,660,036 18,638,018
 Property and Equipment, at cost:
 Equipment 1,281,549 1,211,037
 Furniture and fixtures 336,744 295,654

 Leasehold improvements 158,075 158,075
 Total 1,776,368 1,664,766
 Less-Accumulated depreciation
 and amortization 629,364 561,220
 Total 1,147,004 1,103,546
 Other assets, net 72,152 67,914
 Total $19,879,192 $19,809,478
 LIABILITIES AND STOCKHOLDERS' EQUITY
 Current Liabilities:
 Accounts payable $954,693 $1,129,450
 Accrued expenses 1,542,363 1,632,475
 Deferred revenue 390,693 373,354
 Total current liabilities 2,887,749 3,135,279
 Stockholders' Equity:
 Common stock, 1 cent par value -
 Authorized - 10,000,000 shares
 Issued and outstanding - 3,872,267
 and 3,866,317 shares
 at Dec. 31, 1991 and Sept. 30,
 1991, respectively 38,723 38,663
 Capital in excess of par value 13,789,862 13,783,832
 Retained earnings 3,162,858 2,851,704
 Total stockholders' equity 16,991,443 16,674,199
 Total $19,879,192 $19,809,478
 -0- 1/30/92
 /CONTACT: S. David Ellenbogen, president, or Glenn Muir, controller, 617-890-2300, of Hologic, Inc./
 (HOLX) CO: Hologic, Inc. ST: Massachusetts IN: MTC SU: ERN


DD-DH -- NE001 -- 5046 01/30/92 07:46 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 30, 1992
Words:752
Previous Article:SONOCO INTRODUCES NEW 25 PERCENT RECYCLED CONTENT BAG FEATURING GUARANTEED AUDIT TRAIL
Next Article:COMING TO ATLANTA: HOT-NEWS TOPIC -- THE U.S. AUTO BUSINESS
Topics:


Related Articles
HOLOGIC, INC. ANNOUNCES INCREASE IN THIRD QUARTER 1992 RESULTS
HOLOGIC, INC. ANNOUNCES YEAR-END AND FOURTH QUARTER 1992 RESULTS
HOLOGIC, INC. ANNOUNCES FIRST QUARTER 1993 RESULTS
HOLOGIC, INC. ANNOUNCES SECOND QUARTER 1993 RESULTS
HOLOGIC, INC. ANNOUNCES THIRD QUARTER 1993 RESULTS
HOLOGIC, INC. ANNOUNCES YEAR-END AND FOURTH QUARTER 1993 RESULTS
HOLOGIC, INC. RETURNS TO PROFITABILITY IN THE FIRST QUARTER OF FISCAL 1994
Hologic, Inc. Announces Record Revenues and Earnings in the First Quarter of Fiscal 1997
Hologic Announces First Quarter Revenues
Hologic, Inc. Announces Record Revenues in the Third Quarter of Fiscal 1998

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters